TendieTensor TendieTensor
You’re browsing as
Guest
Free Preview
Sign in/sign up to unlock all features.

News  ›  GlobeNewswire Inc.

ALVO Investor News: If You Have Suffered Losses in Alvotech (NASDAQ: ALVO), You Are Encouraged to Contact The Rosen Law Firm About Your Rights

GlobeNewswire Inc. Logo GlobeNewswire Inc. By Rosen Law Firm
ALVO Investor News: If You Have Suffered Losses in Alvotech (NASDAQ: ALVO), You Are Encouraged to Contact The Rosen Law Firm About Your Rights

Rosen Law Firm is investigating potential securities claims for Alvotech shareholders following an FDA Complete Response Letter for their Biologics License Application, which caused a significant stock price drop.

Insights
SOXX   negative

Semiconductor stocks tracked by the ETF dropped 7.4% for the week


ALVO   negative

The company received a Complete Response Letter from FDA for AVT05, resulting in a 34% stock price drop on November 3, 2025, and an additional 4% decline on November 4, 2025. The FDA noted unresolved deficiencies in their manufacturing facility inspection, indicating significant regulatory challenges.